Cross-institution positioning
Jul 14, 2026Strong institutional reduction. 1 reducing, 2 exited across 3 comparable institutions.
Source: Schedule 13 researchEDGEWELL PERSONAL CARE Co
Latest stored close $27.73 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 1 reducing, 2 exited across 3 comparable institutions.
Source: Schedule 13 research1 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdings2 non-amendment material events in the last 90 days; Latest classified evidence: Director or executive change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +1.7% YoY; Net income -52.9% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 77% through its reported 52-week range; +25.8% over one year.
Source: Stored historical price seriesFiled Jul 14, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 23, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Aug 5, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 26, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 19, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Feb 9, 2026 | 8-K | 2.02, 5.02, 5.07, 7.01, 9.01 | Results of operations / financial condition; Director or executive change; Shareholder vote results; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Feb 6, 2026 | 8-K | 2.01, 7.01, 9.01 | Acquisition or disposition of assets; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Nov 13, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Nov 13, 2025 | 8-K | 1.01, 7.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $570.1M | +1.7% |
| Ended Mar 31, 2026 | $519.5M | +0.6% |
| Ended Dec 31, 2025 | $422.8M | +1.9% |
| Ended Jun 30, 2025 | $560.4M | -13.5% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Sep 30, 2025 | $2.2B | -1.3% |
| Ended Sep 30, 2024 | $2.3B | +0.1% |
| Ended Sep 30, 2023 | $2.3B | +3.7% |
| Ended Sep 30, 2022 | $2.2B | +4.0% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 2.0M | $27.73 | |||
| Dimensional Fund Advisors CIK0000354204 | Jun 30, 2026 observed Jul 14, 2026 filed · 14d Schedule 13G amendment | Exit below reporting threshold | 1.9M -758.6K | 4.00% -1.60 pts | $26.86 | $27.45 | $27.73 |
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 29, 2026 filed · 29d Initial Schedule 13G | Initial Schedule 13G | 2.4M | 5.09% | $21.34 | $21.75 | $27.73 |
Compare EPC with other securities showing similar institutional activity or recent accumulation across several tracked institutions.